Biogen eyes potential acquisitions – Stat News

Jan 13 (Reuters) – Biogen Inc (BIIB.O) is working with investment bank Goldman Sachs (GS.N) to find potential targets for acquisitions, Stat News reported on Thursday, citing an unnamed source.The report said the company’s board had warmed to the idea of acquisitions amid the turmoil surrounding its controversial Alzheimer’s drug Aduhelm.Biogen did not immediately reply to a Reuters request for comment on the report.Register now for FREE unlimited access to Reuters.comRegisterOn Tuesday, the U.S. Centers for Medicaid and Medicare Services (CMS) said it would cover Aduhelm, and similar treatments, only for patients enrolled in …
Read more…….